Firms can do much individually and even more collectively to prevent terminal sterilization capacity shortfalls from triggering parenteral drug shortages, a sterilization expert told the ISPE Aseptic Conference in March.
Emily Craven, Boston Scientific’s director, global sterility assurance, shared her advice on the eve of the Environmental Protection Agency’s 11 April proposal to require that commercial sterilizers reduce emissions...